Sunday, 1 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Results Correction

Curis Lifesciences Results Correction

Curis Lifesciences Limited submitted clarifications and corrected financial results for FY2026 following NSE queries. The update rectifies XBRL discrepancies and integrates issue proceed utilization disclosures.

Source

NSE filing, NSE: CURIS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Curis Lifesciences Ltd: key numbers

Share price
₹180.00
Market cap
₹145.5 Cr
Revenue (annual)
₹60.63 Cr
Net profit (annual)
₹6.92 Cr
P/E (TTM)
21.0×Sector 45.9×
Promoter holding
68.03%
FII holding
1.05%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Curis Lifesciences Ltd

All →

Other results correction announcements

All →